Filed: 5/15/2024ACC: 0001937964-24-000004
📋 What this filing means
ARTIA GLOBAL PARTNERS LP filed this quarterly 13F‑HR report disclosing 49 equity positions with a total reported market value of $497.51M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
49
Positions
$497.51M
Total AUM (reported)
5.83M
Total Shares
Allocation by class
COM$272.55M54.8%
PUT$89.47M18.0%
ADR$88.82M17.9%
SPONSORED ADR$28.81M5.8%
COM NEW$7.34M1.5%
COM PAR $.01$3.21M0.6%
SPONSORED ADS$2.10M0.4%
Portfolio Concentration
Top 3$250.32M50.3%
4–10$155.15M31.2%
11–25$64.64M13.0%
Rest$27.40M5.5%
Top 3 weight
50.3%
Top 10 weight
81.5%
Voting Authority Distribution
Total shares with voting rights: 5.83M
Sole
Full voting authority
5.83M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole49
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings49
Rows:
ELI LILLY & CO
SOLEShares115K
TypeSH
Market value$89.47M
17.98%
Sole
115K
Shared
0.00
None
0.00
NOVO-NORDISK A S
SOLEShares691.74K
TypeSH
Market value$88.82M
17.85%
Sole
691.74K
Shared
0.00
None
0.00
ELI LILLY & CO
SOLEShares92.59K
TypeSH
Market value$72.03M
14.48%
Sole
92.59K
Shared
0.00
None
0.00
MERCK & CO INC
SOLEShares379.20K
TypeSH
Market value$50.04M
10.06%
Sole
379.20K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares433.58K
TypeSH
Market value$35.55M
7.15%
Sole
433.58K
Shared
0.00
None
0.00
ABBVIE INC
SOLEShares90.82K
TypeSH
Market value$16.54M
3.32%
Sole
90.82K
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES INC
SOLEShares210.10K
TypeSH
Market value$14.54M
2.92%
Sole
210.10K
Shared
0.00
None
0.00
ARGENX SE
SOLEShares34.24K
TypeSH
Market value$13.48M
2.71%
Sole
34.24K
Shared
0.00
None
0.00
ASTRAZENECA PLC
SOLEShares190.75K
TypeSH
Market value$12.92M
2.60%
Sole
190.75K
Shared
0.00
None
0.00
VERTEX PHARMACEUTICALS INC
SOLEShares28.90K
TypeSH
Market value$12.08M
2.43%
Sole
28.90K
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares87.85K
TypeSH
Market value$7.01M
1.41%
Sole
87.85K
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares724.68K
TypeSH
Market value$6.59M
1.33%
Sole
724.68K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares89.53K
TypeSH
Market value$6.28M
1.26%
Sole
89.53K
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares45K
TypeSH
Market value$6.21M
1.25%
Sole
45K
Shared
0.00
None
0.00
DISC MEDICINE INC
SOLEShares87.04K
TypeSH
Market value$5.42M
1.09%
Sole
87.04K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares76.25K
TypeSH
Market value$5.21M
1.05%
Sole
76.25K
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares61.59K
TypeSH
Market value$4.09M
0.82%
Sole
61.59K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares85.77K
TypeSH
Market value$4.01M
0.81%
Sole
85.77K
Shared
0.00
None
0.00
PROTAGONIST THERAPEUTICS INC
SOLEShares124.44K
TypeSH
Market value$3.60M
0.72%
Sole
124.44K
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares119.49K
TypeSH
Market value$3.39M
0.68%
Sole
119.49K
Shared
0.00
None
0.00
INSMED INC
SOLEShares118.24K
TypeSH
Market value$3.21M
0.64%
Sole
118.24K
Shared
0.00
None
0.00
SPRINGWORKS THERAPEUTICS INC
SOLEShares53.93K
TypeSH
Market value$2.65M
0.53%
Sole
53.93K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares15.89K
TypeSH
Market value$2.40M
0.48%
Sole
15.89K
Shared
0.00
None
0.00
IDEAYA BIOSCIENCES INC
SOLEShares52.49K
TypeSH
Market value$2.30M
0.46%
Sole
52.49K
Shared
0.00
None
0.00
MERUS N V
SOLEShares50.17K
TypeSH
Market value$2.26M
0.45%
Sole
50.17K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ELI LILLY & COSOLE | PUT | 115K | SH | $89.47M 17.98% | 115K | 0.00 | 0.00 |
NOVO-NORDISK A SSOLE | ADR | 691.74K | SH | $88.82M 17.85% | 691.74K | 0.00 | 0.00 |
ELI LILLY & COSOLE | COM | 92.59K | SH | $72.03M 14.48% | 92.59K | 0.00 | 0.00 |
MERCK & CO INCSOLE | COM | 379.20K | SH | $50.04M 10.06% | 379.20K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 433.58K | SH | $35.55M 7.15% | 433.58K | 0.00 | 0.00 |
ABBVIE INCSOLE | COM | 90.82K | SH | $16.54M 3.32% | 90.82K | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIES INCSOLE | COM | 210.10K | SH | $14.54M 2.92% | 210.10K | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 34.24K | SH | $13.48M 2.71% | 34.24K | 0.00 | 0.00 |
ASTRAZENECA PLCSOLE | SPONSORED ADR | 190.75K | SH | $12.92M 2.60% | 190.75K | 0.00 | 0.00 |
VERTEX PHARMACEUTICALS INCSOLE | COM | 28.90K | SH | $12.08M 2.43% | 28.90K | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 87.85K | SH | $7.01M 1.41% | 87.85K | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 724.68K | SH | $6.59M 1.33% | 724.68K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 89.53K | SH | $6.28M 1.26% | 89.53K | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 45K | SH | $6.21M 1.25% | 45K | 0.00 | 0.00 |
DISC MEDICINE INCSOLE | COM | 87.04K | SH | $5.42M 1.09% | 87.04K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 76.25K | SH | $5.21M 1.05% | 76.25K | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | COM | 61.59K | SH | $4.09M 0.82% | 61.59K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 85.77K | SH | $4.01M 0.81% | 85.77K | 0.00 | 0.00 |
PROTAGONIST THERAPEUTICS INCSOLE | COM | 124.44K | SH | $3.60M 0.72% | 124.44K | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 119.49K | SH | $3.39M 0.68% | 119.49K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 118.24K | SH | $3.21M 0.64% | 118.24K | 0.00 | 0.00 |
SPRINGWORKS THERAPEUTICS INCSOLE | COM | 53.93K | SH | $2.65M 0.53% | 53.93K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 15.89K | SH | $2.40M 0.48% | 15.89K | 0.00 | 0.00 |
IDEAYA BIOSCIENCES INCSOLE | COM | 52.49K | SH | $2.30M 0.46% | 52.49K | 0.00 | 0.00 |
MERUS N VSOLE | COM | 50.17K | SH | $2.26M 0.45% | 50.17K | 0.00 | 0.00 |
Page 1 of 2